PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Amphastar Pharmaceuticals, Inc. (AMPH)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS03209R1032
CUSIP03209R103
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market Cap$2.12B
EPS$2.91
PE Ratio14.87
PEG Ratio2.77
Revenue (TTM)$676.21M
Gross Profit (TTM)$248.86M
EBITDA (TTM)$256.09M
Year Range$38.43 - $67.66
Target Price$63.25
Short %12.43%
Short Ratio12.02

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Amphastar Pharmaceuticals, Inc.

Popular comparisons: AMPH vs. ARCT, AMPH vs. COST, AMPH vs. VOO, AMPH vs. MA, AMPH vs. SPY, AMPH vs. NVO, AMPH vs. AVGO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Amphastar Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


100.00%200.00%300.00%400.00%500.00%600.00%December2024FebruaryMarchAprilMay
379.71%
170.78%
AMPH (Amphastar Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Amphastar Pharmaceuticals, Inc. had a return of -32.13% year-to-date (YTD) and -4.90% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-32.13%11.24%
1 month2.10%4.04%
6 months-22.85%16.49%
1 year-4.90%26.17%
5 years (annualized)16.18%13.76%
10 years (annualized)N/A10.70%

Monthly Returns

The table below presents the monthly returns of AMPH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-13.73%-12.72%-5.71%-6.06%-32.13%
20237.99%5.29%17.70%-4.61%24.04%29.52%5.60%-12.16%-13.73%-1.57%24.41%9.82%120.74%
2022-0.86%20.01%29.56%-1.20%4.71%-6.33%7.47%-20.83%-5.07%9.96%-4.56%-4.98%20.31%
2021-9.60%-3.58%4.51%-5.02%8.74%6.55%3.92%-6.16%-3.31%-1.74%4.71%19.07%15.81%
2020-1.97%-18.61%-3.57%14.22%9.97%20.49%-10.86%1.80%-8.00%4.48%-9.34%13.23%4.25%
201914.37%9.18%-17.79%5.68%-10.84%9.66%-4.55%11.46%-11.71%-2.60%1.01%-1.13%-3.07%
2018-3.12%-1.50%2.12%1.81%-17.23%-3.42%14.35%8.77%1.37%-6.70%21.00%-8.38%3.43%
2017-14.50%-1.78%-6.27%4.14%13.05%4.63%-3.25%-7.35%11.62%1.12%8.41%-1.79%4.45%
2016-15.32%-12.61%13.96%2.50%27.89%2.48%0.37%17.43%-0.16%-4.38%11.74%-9.13%29.44%
20154.48%15.42%6.86%-3.34%6.09%14.60%-7.51%-20.85%-9.17%1.28%29.65%-7.30%22.57%
201414.40%-11.29%36.15%-3.64%-12.96%2.86%11.31%32.69%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AMPH is 37, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of AMPH is 3737
AMPH (Amphastar Pharmaceuticals, Inc.)
The Sharpe Ratio Rank of AMPH is 3939Sharpe Ratio Rank
The Sortino Ratio Rank of AMPH is 3636Sortino Ratio Rank
The Omega Ratio Rank of AMPH is 3636Omega Ratio Rank
The Calmar Ratio Rank of AMPH is 3737Calmar Ratio Rank
The Martin Ratio Rank of AMPH is 3939Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


AMPH
Sharpe ratio
The chart of Sharpe ratio for AMPH, currently valued at -0.11, compared to the broader market-2.00-1.000.001.002.003.004.00-0.11
Sortino ratio
The chart of Sortino ratio for AMPH, currently valued at 0.16, compared to the broader market-4.00-2.000.002.004.006.000.16
Omega ratio
The chart of Omega ratio for AMPH, currently valued at 1.02, compared to the broader market0.501.001.502.001.02
Calmar ratio
The chart of Calmar ratio for AMPH, currently valued at -0.12, compared to the broader market0.002.004.006.00-0.12
Martin ratio
The chart of Martin ratio for AMPH, currently valued at -0.21, compared to the broader market-10.000.0010.0020.0030.00-0.21
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.43, compared to the broader market-2.00-1.000.001.002.003.004.002.43
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.44, compared to the broader market-4.00-2.000.002.004.006.003.44
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.43, compared to the broader market0.501.001.502.001.43
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.96, compared to the broader market0.002.004.006.001.96
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.23, compared to the broader market-10.000.0010.0020.0030.009.23

Sharpe Ratio

The current Amphastar Pharmaceuticals, Inc. Sharpe ratio is -0.11. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Amphastar Pharmaceuticals, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00December2024FebruaryMarchAprilMay
-0.11
2.43
AMPH (Amphastar Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Amphastar Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-40.00%-30.00%-20.00%-10.00%0.00%December2024FebruaryMarchAprilMay
-35.42%
-0.29%
AMPH (Amphastar Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Amphastar Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Amphastar Pharmaceuticals, Inc. was 49.92%, occurring on Mar 20, 2020. Recovery took 456 trading sessions.

The current Amphastar Pharmaceuticals, Inc. drawdown is 35.42%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-49.92%Mar 4, 2019266Mar 20, 2020456Jan 10, 2022722
-43.39%Nov 18, 201678Mar 14, 2017420Nov 9, 2018498
-42.11%Jun 26, 2015170Feb 29, 2016115Aug 11, 2016285
-40.54%Aug 9, 2023175Apr 18, 2024
-35.49%Apr 14, 2022144Nov 8, 2022109Apr 18, 2023253

Volatility

Volatility Chart

The current Amphastar Pharmaceuticals, Inc. volatility is 8.26%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%December2024FebruaryMarchAprilMay
8.26%
3.00%
AMPH (Amphastar Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Amphastar Pharmaceuticals, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items